Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique fusion mutations that may be therapeutically targetable, according to results presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Coronary arterial inflammation linked to high cardiac event risk even without CAD
Researchers in The Lancet highlight coronary arterial inflammation’s role in increasing major adverse cardiac events and cardiovascular deaths, irrespective of coronary artery disease presence.
June 4, 2024